Hiroo Takayama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroo Takayama has a total of 494 co-authors. Here are the top co-authors by number of shared publications:
Paul Kurlansky
27 shared publicationsYanling Zhao
26 shared publicationsIsaac George
Division of Cardiothoracic and Vascular Surgery, Columbia University Irving Medical Center, New York, New York
17 shared publicationsKoji Takeda
Division of Cardiothoracic and Vascular Surgery, New York Presbyterian Hospital/Columbia University Medical Center , NY
15 shared publications- Koji Takeda
Division of Cardiothoracic and Vascular Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA
14 shared publications - Yoshifumi Naka
Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Medical Center, New York, NY
13 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2477
The Outcomes of Distal Aortic Reinterventions After Zone 2 Arch Replacement
Background: Zone 2 aortic arch replacement (Z2R) is an effective strategy for treating aortic pathology. However, the frequency and consequences of distal reinterventions (DRs) remain unknown. We evaluated the outcomes associated with planned distal reinterventions (PDRs) and unplanned distal reinterventions (UDRs) after Z2R. Methods: Patients requiring PDRs or UDRs after Z2R between 2007 and 2024 were reviewed. CTA/MRA scans were analyzed for aortic remodeling. The primary outcome was a composite of postoperative mortality, dialysis, paralysis and stroke (thoracoabdominal aortic aneurysm life-altering event; TALE) after DR. Secondary outcomes included cumulative reintervention burden, progression of false lumen thrombosis, and survival. Results: Among 111 Z2R patients followed for a median of 3.5 (1.5, 6.6) years, 55 (49.5%) required a total of 82 DRs: 25 with ≥1 UDR and 30 with only PDRs. PDRs were more often endovascular (93% vs. 72%, p = 0.02). TALE rates were similar between PDRs and UDRs (PDR: 9.3% vs. UDR: 12.8%, p = 0.88). Patients with UDRs had a greater cumulative reintervention burden (MCF 3, 95% CI 2–5 vs. MCF 1, 95% CI 1–1; p = 0.005). Neither PDRs nor UDRs were associated with differences in risk-adjusted mortality compared with no DR. Among dissection patients, PDR (63%) and UDR (100%) were associated with greater progression of false lumen thrombosis in the distal descending aorta compared to no DR (47%) (p = 0.04). Conclusions: Distal reinterventions after Zone 2 arch replacement are common and represent an important component of longitudinal aortic management. Patients undergoing exclusively planned distal reinterventions demonstrated a lower observed cumulative procedural burden than patients who experienced unplanned interventions. However, differences in baseline pathology, treatment pathways, and selection bias limit causal interpretation. Larger studies are needed to determine whether deliberate staging improves long-term outcomes.
- 29 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2477
Open AccessThe Outcomes of Distal Aortic Reinterventions After Zone 2 Arch Replacement
Background: Zone 2 aortic arch replacement (Z2R) is an effective strategy for treating aortic pathology. However, the frequency and consequences of distal reinterventions (DRs) remain unknown. We evaluated the outcomes associated with planned distal reinterventions (PDRs) and unplanned distal reinterventions (UDRs) after Z2R. Methods: Patients requiring PDRs or UDRs after Z2R between 2007 and 2024 were reviewed. CTA/MRA scans were analyzed for aortic remodeling. The primary outcome was a composite of postoperative mortality, dialysis, paralysis and stroke (thoracoabdominal aortic aneurysm life-altering event; TALE) after DR. Secondary outcomes included cumulative reintervention burden, progression of false lumen thrombosis, and survival. Results: Among 111 Z2R patients followed for a median of 3.5 (1.5, 6.6) years, 55 (49.5%) required a total of 82 DRs: 25 with ≥1 UDR and 30 with only PDRs. PDRs were more often endovascular (93% vs. 72%, p = 0.02). TALE rates were similar between PDRs and UDRs (PDR: 9.3% vs. UDR: 12.8%, p = 0.88). Patients with UDRs had a greater cumulative reintervention burden (MCF 3, 95% CI 2–5 vs. MCF 1, 95% CI 1–1; p = 0.005). Neither PDRs nor UDRs were associated with differences in risk-adjusted mortality compared with no DR. Among dissection patients, PDR (63%) and UDR (100%) were associated with greater progression of false lumen thrombosis in the distal descending aorta compared to no DR (47%) (p = 0.04). Conclusions: Distal reinterventions after Zone 2 arch replacement are common and represent an important component of longitudinal aortic management. Patients undergoing exclusively planned distal reinterventions demonstrated a lower observed cumulative procedural burden than patients who experienced unplanned interventions. However, differences in baseline pathology, treatment pathways, and selection bias limit causal interpretation. Larger studies are needed to determine whether deliberate staging improves long-term outcomes.
- 20 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (20)
Exercise and Thoracic Aortic Aneurysms: A Paradigm Shift Toward Informed, Personalized Activity Guidelines
Exercise is widely recognized for its cardiovascular benefits; however, its safety and role in patients with thoracic aortic aneurysms (TAAs) remains complex due to its distinctive biomechanical vulnerabilities. Fundamentally different from abdominal aortic aneurysms, TAAs develop from distinct pathophysiological processes that affect their hemodynamic responses to stressors and influence their risk of adverse aortic events. Exercise induces acute hemodynamic changes, including increased stroke volume, systolic and pulse pressures, and transient aortic stiffening. These changes impose mechanical stress on the aortic wall, potentially accelerating aneurysm progression or triggering adverse aortic events. Although moderate aerobic exercise generally appears safe with potential cardiovascular benefits, evidence supporting safe practices in TAAs is limited. Current guidelines frequently extrapolate from abdominal aortic aneurysm data, which overlook the specificities of the thoracic aorta. This review underscores the urgent need for comprehensive research, using advanced imaging, biomarker profiling, and real‐time hemodynamic monitoring to understand how different exercise modalities and intensities affect TAAs. Well‐designed prospective studies are crucial to improve risk stratification, optimize antihypertensive strategies, develop personalized exercise prescriptions, and provide evidence‐informed guidance to patients. Perioperative strategies like prehabilitation and structured postoperative rehabilitation show promise but lack rigorous evaluation. Ultimately, this work advocates a paradigm shift from conservative inactivity toward informed, individualized physical activity regimens tailored to each patient's risk profile. This approach aims to maximize cardiovascular benefits while minimizing adverse aortic events, thereby improving overall health and quality of life in patients with TAAs.
- 20 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (20)
Exercise and Thoracic Aortic Aneurysms: A Paradigm Shift Toward Informed, Personalized Activity Guidelines
Exercise is widely recognized for its cardiovascular benefits; however, its safety and role in patients with thoracic aortic aneurysms (TAAs) remains complex due to its distinctive biomechanical vulnerabilities. Fundamentally different from abdominal aortic aneurysms, TAAs develop from distinct pathophysiological processes that affect their hemodynamic responses to stressors and influence their risk of adverse aortic events. Exercise induces acute hemodynamic changes, including increased stroke volume, systolic and pulse pressures, and transient aortic stiffening. These changes impose mechanical stress on the aortic wall, potentially accelerating aneurysm progression or triggering adverse aortic events. Although moderate aerobic exercise generally appears safe with potential cardiovascular benefits, evidence supporting safe practices in TAAs is limited. Current guidelines frequently extrapolate from abdominal aortic aneurysm data, which overlook the specificities of the thoracic aorta. This review underscores the urgent need for comprehensive research, using advanced imaging, biomarker profiling, and real‐time hemodynamic monitoring to understand how different exercise modalities and intensities affect TAAs. Well‐designed prospective studies are crucial to improve risk stratification, optimize antihypertensive strategies, develop personalized exercise prescriptions, and provide evidence‐informed guidance to patients. Perioperative strategies like prehabilitation and structured postoperative rehabilitation show promise but lack rigorous evaluation. Ultimately, this work advocates a paradigm shift from conservative inactivity toward informed, individualized physical activity regimens tailored to each patient's risk profile. This approach aims to maximize cardiovascular benefits while minimizing adverse aortic events, thereby improving overall health and quality of life in patients with TAAs.
- 21 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (14) , e049636
Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery
Background: Transvenous pacemaker implantation after tricuspid valve surgery may cause adverse outcomes due to lead–valve interactions. Although leadless pacemakers may mitigate these risks, empirical data remain limited. Methods: We compared outcomes of leadless versus transvenous pacemakers following tricuspid surgery using a target trial emulation framework. We analyzed Medicare beneficiaries aged ≥65 years who underwent tricuspid valve surgery and received a pacemaker during the index admission between 2017 and 2021, using propensity score matching weight analysis to control for confounders. Primary outcomes were in‐hospital death and 2‐year heart failure hospitalization. Secondary outcomes included 2‐year death. Results: We included 185 and 1336 patients in the leadless and transvenous groups, respectively. Use of leadless pacemakers increased from 6.3% in 2017 to 17.5% in 2021. Leadless pacemaker recipients more often underwent tricuspid valve replacement (29.2% versus 8.5%) while concomitant mitral surgery was less common (69.2% versus 86.8%). After adjustment, we found no evidence that in‐hospital death (adjusted odds ratio, 1.82 [95% CI, 0.65–5.13] for leadless) and 2‐year heart failure hospitalizations (subdistribution hazard ratio [HR], 0.88 [95% CI, 0.60–1.30] for leadless) differed between the 2 groups. We also found no evidence that 2‐year death (adjusted HR, 1.04 [95% CI, 0.69–1.57] for leadless) differed between groups. Conclusions: No statistically significant differences were detected between leadless versus transvenous pacemaker implantations after tricuspid valve surgery. However, CIs were wide, and a clinically meaningful difference in either direction cannot be excluded. The study may therefore be underpowered, and the absence of echocardiographic data limits assessment of tricuspid regurgitation, warranting prospective studies.
- 21 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (14) , e049636
Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery
Background: Transvenous pacemaker implantation after tricuspid valve surgery may cause adverse outcomes due to lead–valve interactions. Although leadless pacemakers may mitigate these risks, empirical data remain limited. Methods: We compared outcomes of leadless versus transvenous pacemakers following tricuspid surgery using a target trial emulation framework. We analyzed Medicare beneficiaries aged ≥65 years who underwent tricuspid valve surgery and received a pacemaker during the index admission between 2017 and 2021, using propensity score matching weight analysis to control for confounders. Primary outcomes were in‐hospital death and 2‐year heart failure hospitalization. Secondary outcomes included 2‐year death. Results: We included 185 and 1336 patients in the leadless and transvenous groups, respectively. Use of leadless pacemakers increased from 6.3% in 2017 to 17.5% in 2021. Leadless pacemaker recipients more often underwent tricuspid valve replacement (29.2% versus 8.5%) while concomitant mitral surgery was less common (69.2% versus 86.8%). After adjustment, we found no evidence that in‐hospital death (adjusted odds ratio, 1.82 [95% CI, 0.65–5.13] for leadless) and 2‐year heart failure hospitalizations (subdistribution hazard ratio [HR], 0.88 [95% CI, 0.60–1.30] for leadless) differed between the 2 groups. We also found no evidence that 2‐year death (adjusted HR, 1.04 [95% CI, 0.69–1.57] for leadless) differed between groups. Conclusions: No statistically significant differences were detected between leadless versus transvenous pacemaker implantations after tricuspid valve surgery. However, CIs were wide, and a clinically meaningful difference in either direction cannot be excluded. The study may therefore be underpowered, and the absence of echocardiographic data limits assessment of tricuspid regurgitation, warranting prospective studies.
- Open Access
- 10 April 2026
- Published by Elsevier in JTCVS Open
- Vol. 31
Hypoxemia after thoracic aortic aneurysm repair
- 10 April 2026
- Published by Elsevier in JTCVS Open
- Vol. 31
Open AccessHypoxemia after thoracic aortic aneurysm repair
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (4) , 419
Narrative review of fluid dynamics in the left ventricle: from the perspective of aortic regurgitation
Background and Objective: From a fluid dynamics perspective, understanding intraventricular blood flow is essential for clarifying the mechanisms, progression, and potential therapeutic targets of various cardiac diseases. Recent advancements in imaging techniques have enabled the visualization of left ventricle (LV) blood flow, particularly the vortex formed during diastole. However, the inherently complex and dynamic nature of LV fluid motion makes the quantitative assessment of vortex function highly challenging. The impact of aortic regurgitation (AR) on LV fluid dynamics is equally critical for understanding the progression of cardiac dysfunction, yet its exact influence remains largely unclear. This manuscript is a narrative review of this novel perspective of AR in the context of fluid dynamics. Methods: Articles from PubMed database and Google Scholar regarding LV blood flow and vortex assessment were reviewed. For the initial research, articles between 2010 and 2025 were prioritized, including original articles, case reports, and reviews. Following the initial search, additional articles were considered based on manual searches of references from the retrieved literature. Key Content and Findings: AR jets have several interactions with LV blood flow depending on its direction, and the eccentric jet can be oriented in several directions based on the relationship to the mitral inflow location. Conclusions: Various orientations of eccentric AR jet are possible and LV blood flow trajectory is modulated by the direction of AR jets. A reproducible classification of AR jet direction, combined with the quantification of vortex alterations according to jet direction, represents a vital step in elucidating the specific roles of these vortices in cardiac function.
- 1 April 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (4) , 419
Open AccessNarrative review of fluid dynamics in the left ventricle: from the perspective of aortic regurgitation
Background and Objective: From a fluid dynamics perspective, understanding intraventricular blood flow is essential for clarifying the mechanisms, progression, and potential therapeutic targets of various cardiac diseases. Recent advancements in imaging techniques have enabled the visualization of left ventricle (LV) blood flow, particularly the vortex formed during diastole. However, the inherently complex and dynamic nature of LV fluid motion makes the quantitative assessment of vortex function highly challenging. The impact of aortic regurgitation (AR) on LV fluid dynamics is equally critical for understanding the progression of cardiac dysfunction, yet its exact influence remains largely unclear. This manuscript is a narrative review of this novel perspective of AR in the context of fluid dynamics. Methods: Articles from PubMed database and Google Scholar regarding LV blood flow and vortex assessment were reviewed. For the initial research, articles between 2010 and 2025 were prioritized, including original articles, case reports, and reviews. Following the initial search, additional articles were considered based on manual searches of references from the retrieved literature. Key Content and Findings: AR jets have several interactions with LV blood flow depending on its direction, and the eccentric jet can be oriented in several directions based on the relationship to the mitral inflow location. Conclusions: Various orientations of eccentric AR jet are possible and LV blood flow trajectory is modulated by the direction of AR jets. A reproducible classification of AR jet direction, combined with the quantification of vortex alterations according to jet direction, represents a vital step in elucidating the specific roles of these vortices in cardiac function.
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (4) , 420
Frozen elephant trunk: a narrative review of global and temporal trends
Background and Objective: The frozen elephant trunk (FET) repair has transitioned from a niche procedure to a widely adopted strategy across Asia, Europe, and North America. Multicenter registries demonstrate improving early outcomes over time, consistent with learning curve effects. Regional differences persist in case mix, device availability, and utilization. No study has systematically measured these regional differences. We aim to describe the history, evolution, and current landscape of FET worldwide. Methods: A narrative review of English-language adult studies from PubMed, Google Scholar and International Clinical Guidelines (January 2010–September 2025) was performed using procedural and device terminology. Multicenter registries and large single-center series reporting case volumes and outcomes (mortality, stroke, spinal cord ischemia) were included. Data on indication, regional techniques, device use, and clinical outcomes were extracted to identify global and temporal trends. Key Content and Findings: FET utilization demonstrates wide regional variability, further obscured by heterogeneity in published studies reporting either acute type A aortic dissection (ATAAD) specific or mixed pathology cohorts. China exhibits the highest utilization (48–78% of ATAAD patients). Japan has shown substantial growth over the past decade, with contemporary data indicating FET use in 20% of thoracic aortic cases. In contrast, United States utilization remains low (Conclusions: Global FET volume has risen markedly over two decades, driven by standardization of neuroprotective techniques and advanced hybrid prostheses. A core set of principles has emerged establishing FET as a safe and versatile option for complex aortic disease worldwide. However, differences in devices, patient populations, and procedural indications remain.
- 1 April 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (4) , 420
Open AccessFrozen elephant trunk: a narrative review of global and temporal trends
Background and Objective: The frozen elephant trunk (FET) repair has transitioned from a niche procedure to a widely adopted strategy across Asia, Europe, and North America. Multicenter registries demonstrate improving early outcomes over time, consistent with learning curve effects. Regional differences persist in case mix, device availability, and utilization. No study has systematically measured these regional differences. We aim to describe the history, evolution, and current landscape of FET worldwide. Methods: A narrative review of English-language adult studies from PubMed, Google Scholar and International Clinical Guidelines (January 2010–September 2025) was performed using procedural and device terminology. Multicenter registries and large single-center series reporting case volumes and outcomes (mortality, stroke, spinal cord ischemia) were included. Data on indication, regional techniques, device use, and clinical outcomes were extracted to identify global and temporal trends. Key Content and Findings: FET utilization demonstrates wide regional variability, further obscured by heterogeneity in published studies reporting either acute type A aortic dissection (ATAAD) specific or mixed pathology cohorts. China exhibits the highest utilization (48–78% of ATAAD patients). Japan has shown substantial growth over the past decade, with contemporary data indicating FET use in 20% of thoracic aortic cases. In contrast, United States utilization remains low (Conclusions: Global FET volume has risen markedly over two decades, driven by standardization of neuroprotective techniques and advanced hybrid prostheses. A core set of principles has emerged establishing FET as a safe and versatile option for complex aortic disease worldwide. However, differences in devices, patient populations, and procedural indications remain.
- Open Access
- 25 February 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (4)
Free Versus In situ Right Internal Mammary Artery as a Conduit in Coronary Artery Bypass Surgery: A Meta-Analysis
Objectives: There is debate regarding the optimal choice for a second conduit in coronary artery bypass grafting. The right internal mammary artery (RIMA) is commonly employed as a second conduit; however, it is unclear whether the free (fRIMA) or in situ (isRIMA) configuration yields superior outcomes. We performed a systematic review and meta-analysis to compare clinical outcomes between fRIMA and isRIMA as the second conduit. Methods: A comprehensive search of PubMed (MEDLINE), EMBASE, and CENTRAL was performed through May 2025 to identify studies comparing outcomes in patients undergoing coronary artery bypass grafting with either fRIMA or isRIMA as a second conduit. The outcomes of interest were overall mortality, graft occlusion, major adverse cardiac events (MACE), and repeat revascularization. Data with 95% confidence intervals (CIs) were extracted. Pooled analysis was performed using a random-effects model. Results: A total of 13 studies with 9899 patients were included (fRIMA, n = 3095; isRIMA, n = 6804). The median study follow-up duration ranged from 1 to 20 years across the studies. No statistically significant differences were observed in overall mortality (hazard ratio [95% CI] = 1.16 [0.79-1.69]), graft occlusion (1.04 [0.90-1.21]), MACE (0.87 [0.62-1.21]), and repeat revascularization (1.34 [0.68-2.66]). Conclusions: In this meta-analysis, no statistically significant differences were observed between fRIMA and isRIMA configurations across the evaluated clinical outcomes. These findings suggest that, within the limitations of available evidence, the choice between fRIMA and isRIMA may be guided by clinical context, surgeon preference, patient anatomy, and target vessel characteristics rather than expected differences in major clinical outcomes.
- 25 February 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (4)
Open AccessFree Versus In situ Right Internal Mammary Artery as a Conduit in Coronary Artery Bypass Surgery: A Meta-Analysis
Objectives: There is debate regarding the optimal choice for a second conduit in coronary artery bypass grafting. The right internal mammary artery (RIMA) is commonly employed as a second conduit; however, it is unclear whether the free (fRIMA) or in situ (isRIMA) configuration yields superior outcomes. We performed a systematic review and meta-analysis to compare clinical outcomes between fRIMA and isRIMA as the second conduit. Methods: A comprehensive search of PubMed (MEDLINE), EMBASE, and CENTRAL was performed through May 2025 to identify studies comparing outcomes in patients undergoing coronary artery bypass grafting with either fRIMA or isRIMA as a second conduit. The outcomes of interest were overall mortality, graft occlusion, major adverse cardiac events (MACE), and repeat revascularization. Data with 95% confidence intervals (CIs) were extracted. Pooled analysis was performed using a random-effects model. Results: A total of 13 studies with 9899 patients were included (fRIMA, n = 3095; isRIMA, n = 6804). The median study follow-up duration ranged from 1 to 20 years across the studies. No statistically significant differences were observed in overall mortality (hazard ratio [95% CI] = 1.16 [0.79-1.69]), graft occlusion (1.04 [0.90-1.21]), MACE (0.87 [0.62-1.21]), and repeat revascularization (1.34 [0.68-2.66]). Conclusions: In this meta-analysis, no statistically significant differences were observed between fRIMA and isRIMA configurations across the evaluated clinical outcomes. These findings suggest that, within the limitations of available evidence, the choice between fRIMA and isRIMA may be guided by clinical context, surgeon preference, patient anatomy, and target vessel characteristics rather than expected differences in major clinical outcomes.
- Open Access
- 16 February 2026
- Published by Elsevier in JTCVS Structural and Endovascular
- Vol. 10, 100103
How to manage residual aortic regurgitation after an aortic valve-sparing operation: Practical tips
- 16 February 2026
- Published by Elsevier in JTCVS Structural and Endovascular
- Vol. 10, 100103
Open AccessHow to manage residual aortic regurgitation after an aortic valve-sparing operation: Practical tips
- Open Access
- 28 October 2025
- Published by Elsevier in JTCVS Open
- Vol. 29, 101493
Aortic root replacement after repaired congenital conotruncal defects: A surgical challenge
- 28 October 2025
- Published by Elsevier in JTCVS Open
- Vol. 29, 101493
Open AccessAortic root replacement after repaired congenital conotruncal defects: A surgical challenge
- 9 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (3)
EACTS Expert Consensus Document on protected cardiac surgery: pre-emptive use of temporary mechanical circulatory support in adult cardiac surgery patients at high risk for perioperative low cardiac output syndrome
Perioperative low cardiac output syndrome (LCOS) remains a significant complication in adult cardiac surgery, contributing to substantial morbidity, prolonged intensive care, and increased mortality. Its incidence is expected to rise further due to the evolving complexity of referred surgical patients, often characterised by advanced age, multiple comorbidities, challenging anatomy, and impaired haemodynamics. Despite advances in pharmacological and perioperative care, outcomes for high-risk patients have not shown significant improvement, prompting interest in temporary mechanical circulatory support (tMCS) as a proactive strategy. This Expert Consensus Document from the European Association for Cardio-Thoracic Surgery (EACTS) presents the first dedicated guidance on the pre-emptive use of tMCS in high-risk adult cardiac surgical patients. Developed by a multidisciplinary task force, it emphasises structured risk stratification, early initiation, and individualised device management informed by interdisciplinary Heart Team discussions. The document proposes clinical pathways for patient selection, defines criteria for tMCS initiation, and provides practical algorithms for various scenarios, including advanced heart failure, cardiogenic shock, and post-cardiotomy LCOS. It reviews the current evidence on available tMCS devices, such as intra-aortic balloon pumps, microaxial flow pumps, veno-arterial extracorporeal life support and hybrid strategies, and addresses perioperative care, intensive care unit protocols, ethical considerations, as well as informed consent and support withdrawal. Despite promising results, substantial knowledge gaps remain, including long-term outcome data, device selection criteria, and cost-effectiveness analyses. This consensus aims to support clinical decision-making, standardise practice, and stimulate research to improve outcomes in a growing population of high-risk surgical patients.
- 9 October 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (3)
EACTS Expert Consensus Document on protected cardiac surgery: pre-emptive use of temporary mechanical circulatory support in adult cardiac surgery patients at high risk for perioperative low cardiac output syndrome
Perioperative low cardiac output syndrome (LCOS) remains a significant complication in adult cardiac surgery, contributing to substantial morbidity, prolonged intensive care, and increased mortality. Its incidence is expected to rise further due to the evolving complexity of referred surgical patients, often characterised by advanced age, multiple comorbidities, challenging anatomy, and impaired haemodynamics. Despite advances in pharmacological and perioperative care, outcomes for high-risk patients have not shown significant improvement, prompting interest in temporary mechanical circulatory support (tMCS) as a proactive strategy. This Expert Consensus Document from the European Association for Cardio-Thoracic Surgery (EACTS) presents the first dedicated guidance on the pre-emptive use of tMCS in high-risk adult cardiac surgical patients. Developed by a multidisciplinary task force, it emphasises structured risk stratification, early initiation, and individualised device management informed by interdisciplinary Heart Team discussions. The document proposes clinical pathways for patient selection, defines criteria for tMCS initiation, and provides practical algorithms for various scenarios, including advanced heart failure, cardiogenic shock, and post-cardiotomy LCOS. It reviews the current evidence on available tMCS devices, such as intra-aortic balloon pumps, microaxial flow pumps, veno-arterial extracorporeal life support and hybrid strategies, and addresses perioperative care, intensive care unit protocols, ethical considerations, as well as informed consent and support withdrawal. Despite promising results, substantial knowledge gaps remain, including long-term outcome data, device selection criteria, and cost-effectiveness analyses. This consensus aims to support clinical decision-making, standardise practice, and stimulate research to improve outcomes in a growing population of high-risk surgical patients.